For patients with psoriasis, treatment adherence and persistence are fundamental if therapeutic goals are to be met. Patient Support Programs (PSPs) may be used as a support tool to assist patients and health care professionals optimize treatment and improve disease management.
Argenziano, G., Amerio, P., Aragone, M.g., Baggini, G., Baldari, M., Castelli, G., et al. (2021). Assessing the Beneficial Impact of a Patient Support Program in Secukinumab-Treated Patients with Psoriasis in Italy. PATIENT PREFERENCE AND ADHERENCE, 15, 2551-2562 [10.2147/PPA.S326498].
Assessing the Beneficial Impact of a Patient Support Program in Secukinumab-Treated Patients with Psoriasis in Italy
Bianchi, Luca
2021-01-01
Abstract
For patients with psoriasis, treatment adherence and persistence are fundamental if therapeutic goals are to be met. Patient Support Programs (PSPs) may be used as a support tool to assist patients and health care professionals optimize treatment and improve disease management.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Assessing the Beneficial Impact of a Patient Support Program in Secukinumab.pdf
solo utenti autorizzati
Licenza:
Copyright dell'editore
Dimensione
1.65 MB
Formato
Adobe PDF
|
1.65 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
